-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: patient advocates
MJFF’s Innovative, New Funding Program Addresses the Entire Therapeutic Pipeline
To date, the Michael J. Fox Foundation for Parkinson’s Research has funded over $297 million in research, $77 million of which has been awarded to more than 160 unique, industry-led projects. In June 2012, MJFF announced its newest funding mechanism, the Therapeutic Pipeline Program (TPP), which combines MJFF’s previous Therapeutics Development Initiative (TDI), Repositioning Drugs for PD, and Clinical Intervention Awards (CIA) programs into a single, streamlined funding opportunity. Open to both industry and academic Read More >
Psoriasis Awareness Month: Psoriasis isn’t contagious but awareness is!
Each August, the National Psoriasis Foundation (NPF) sponsors Psoriasis Awareness Month, dedicated to raising awareness, educating the public and dispelling myths about the disease. What is psoriasis? Psoriasis isn’t contagious, but awareness is. Learn more at www.psoriasis.org. Photo © National Psoriasis Foundation 2012. Psoriasis is a chronic, noncontagious, genetic autoimmune disease that appears on the skin in red, scaly patches that itch, crack and bleed. It is the most common autoimmune disease in the country, Read More >
Bringing Hope to Patients
No-one expected Hope Bartley to survive after she was born three months early. Thanks to extraordinary biotech medicine, she did. Alena Galan, age 14, is one of only a few thousand patients with a rare disease called MPS. Thanks to the hard work of leading biotech scientists and the approval of a new treatment, she now has a chance to lead a normal life. Lori Lober experienced the unthinkable when she was diagnosed with Stage Read More >
From Despair to Hope, a New World of Treatments
By David Welch, President and Senior Producer, M2 MultiMedia Communications Tonight, Wednesday March 28 at 9:00 EST, a documentary called From Despair to Hope, A New World of Treatments, will be broadcast on WUSA-TV, the CBS affiliate in Washington, D.C. It is sponsored by the Biotechnology Industry Organization. For me, producing this program was a yet another profound reminder of the contributions of biotechnology companies that are helping millions of patients throughout the world live hopeful Read More >
